240 / 510
Cuidados
Continuos
239
BIBLIOGRAFÍA
Siclari VA, Guise TA, Chirgwin JM. Molecular interactions between breast cancer cells and
the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 2006; 25: 621.
Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast
differentiation and activation. Cell 1998; 93: 165-176.
Brown JE, Cook RJ, Major P, et al. Bone turnover markers as predictors of skeletal
complications in prostate cancer, lung cancer, and other solid tumors. J Natl Cancer Inst
2005; 97(1): 59.
Hipp JA1, Springfield DS, Hayes WC. Predicting pathologic fracture risk in the management of
metastatic bone defects. Clin Orthop Relat Res. 1995; 312:120-35
Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, et al. Quality of Life After Palliative
Radiation Therapy for Patients With Painful Bone Metastases: Results of an International
Study Validating the EORTC QLQ-BM22. Int J Radiat Oncol Biol Phys. 2012;84:e337-42
Rades D, Stalpers LJ, Veninga T, et al. Evaluation of 5 radiation schedules and prognostic
factors for metastatic spinal cord compression. J Clin Oncol 2005, 23:3366–3375.
Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the
treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet
2005, 366:643–648.
Yazawa Y, Frassica FJ, Chao EY, et al. Metastatic bone disease. A study of the surgical treatment
of 166 pathologic humeral and femoral fractures. Clin Orthop Relat Res. Feb 1990;251:213-9.
Harrington KD. Orthopaedic management of extremity and pelvic lesions. Clin Orthop Relat
Res. 1995;312:136-47.
Halm H, Richter A, Lerner T, Liljenqvist U. En-bloc spondylectomy and reconstruction for
primary tumors and solitary metastasis of the spine. Orthopade. 2008;37:356-66.
Papanastassiou ID, Phillips FM, Meirhaeghe JV, Berenson JR, Andersson GBJ, Chung G
et al. Comparing effects of kyphoplasty, vertebroplasty, and nonsurgical management in a
systematic review of randomized and non-randomized controlled studies. Eur Spine J. 2012;
21:1826-43.
Ma XL1, Xing D, Ma JX, Xu WG, Wang J, Chen Y. Balloon kyphoplasty versus percutaneous
vertebroplasty in treating osteoporotic vertebral compression fracture: grading the evidence
through a systematic review and meta-analysis. Eur Spine J. 2012; 21:1844-59.
Callstrom MR, Dupuy DE, Solomon SB, et al. Percutaneous image-guided cryoablation of
painful metastases involving bone: multicenter trial. Cancer 2013;119:1033-41.
Rosen SL, Gordon D, Dugan W Jr, et al. Zoledronic acid is superior to pamidronate for the
treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion.
Cancer. 2004;100:36-43.
Saad F, Gleason DM, Murray R, et al. A randomized, placebo-controlled trial of zoledronic acid
in patients with hormone-refractory metastatic prostate carcinoma. J Natl Cancer Inst. 2002;
94:1458-1468.
Rosen LS, Gordon D, Tchekmedyan NS, et al. Long-term efficacy and safety of zoledronic acid
in the treatment of skeletal metastases in patients with non-small cell lung cancer and other
solid tumors: a randomized phase III , doubled –blind, placebo-controlled trial. Cancer. 2004;
100:2613-2621.
Henry DH, Costa L, Goldwasser F, et al. Randomized double-blind study of Denosumab Versus
Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer
(Excluding Breast and Prostate Cancer) or Multiple Myeloma. J Clin Oncol 2011; 29:1125-1132.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.